医学
内科学
肿瘤科
卵巢癌
化疗
分子生物标志物
临床试验
生物标志物
临床研究阶段
癌症
队列
上皮性卵巢癌
新辅助治疗
作者
F. Blanc-Durand,Benoit You,Yahia Adnani,Gaëtan De Rauglaudre,Isabelle Ray-Coquard,Pierre Combe,Cyril Abdeddaim,Florence Joly,G. Ferron,Clotilde Deldycke,Olivier Colomban,Marie-Christine Kaminsky,Jerome Meunier,J. Alexandre,Coriolan Lebreton,Laurence Venat,Laure Favier,C. Louvet,Sophie Abadie‐Lacourtoisie,Eric Pujade Lauraine
摘要
HRD status, KELIM, and TILs are key independent biomarkers in advanced OC. CCNE1 amplifications, although typically associated with platinum resistance, were linked to moderate chemotherapy sensitivity, defining an intermediate prognostic subgroup.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
DW
无极微光
Criminology34
cdercder
秋风
Enigma_GEB
Lo
修仙中
null
Nole
刘泽楷
DOC_XIONG
七颗茶香豆
我想
昏睡的蟠桃
OK
xing_xing
aaaa
学术文献互助
舒服的楷瑞
皖公网安备34019202002308
